Zotepine
CAS No. 26615-21-4
Zotepine ( —— )
产品货号. M27130 CAS No. 26615-21-4
Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic, and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM, and 8 nM, respectively.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥470 | 有现货 |
|
5MG | ¥770 | 有现货 |
|
10MG | ¥1256 | 有现货 |
|
25MG | ¥2535 | 有现货 |
|
50MG | ¥4358 | 有现货 |
|
100MG | ¥6221 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Zotepine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic, and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM, and 8 nM, respectively.
-
产品描述Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic, and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM, and 8 nM, respectively. Zotepine is a second-generation antipsychotic with a primary use as a treatment for schizophrenia, although clinical trials have been conducted into its efficacy as an antimanic agent in patients with acute bipolar mania.
-
同义词——
-
通路GPCR/G Protein
-
靶点Dopamine Receptor
-
受体Gpx4
-
研究领域——
-
适应症——
化学信息
-
CAS Number26615-21-4
-
分子量331.9
-
分子式C18H18ClNOS
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc12
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Kathman SG, et al. A masked zinger to block GPX4. Nat Chem Biol. 2020;16(5):482-483.
产品手册
关联产品
-
GSK598809
GSK598809 (GSK-598809) is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors.
-
Dopamine
Dopamine is an inotropic vasopressor agent and dopamine receptor agonist used in neurological diseases.?
-
Tavapadon
Tavapadon (PF 6649751, PF-06649751) is an orally available dopamine D1 receptor partial agonist for treatment of Parkinson's disease.